Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 4786 AL 4800

Gut microbiome in Parkinson's disease: New insights from meta-analysis

Toh TS, Chong CW, Lim SY, Bowman J, Cirstea M, Lin CH, Chen CC, Appel-Cresswell S, Finlay BB, Tan AH.

Parkinsonism Relat Disord. 2022 Jan;94:1-9. doi: 10.1016/j.parkreldis.2021.11.017. Epub 2021 Nov 17.

[Hallucinations in Patients with Idiopathic Parkinson's Disease]

Weiss D, Höglinger G, Klostermann F, Weise D, Zeuner KE, Reichmann H.

Fortschr Neurol Psychiatr. 2022 Oct;90(10):456-464. doi: 10.1055/a-1670-7111. Epub 2021 Nov 29.

Applications of covalent organic frameworks and their composites in the extraction of pesticides from different samples

Bagheri AR, Aramesh N, Haddad PR.

J Chromatogr A. 2022 Jan 4;1661:462612. doi: 10.1016/j.chroma.2021.462612. Epub 2021 Oct 7.

Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis

Quan W, Li J, Liu L, Zhang Q, Qin Y, Pei X, Chen J.

Neurol Sci. 2022 May;43(5):3145-3152. doi: 10.1007/s10072-021-05754-6. Epub 2021 Nov 29.

Mitochondrial dysfunction as a trigger of programmed axon death

Merlini E, Coleman MP, Loreto A.

Trends Neurosci. 2022 Jan;45(1):53-63. doi: 10.1016/j.tins.2021.10.014. Epub 2021 Nov 29.

Subthalamic burst firing: A pathophysiological target in Parkinson's disease

Tai CH.

Neurosci Biobehav Rev. 2022 Jan;132:410-419. doi: 10.1016/j.neubiorev.2021.11.044. Epub 2021 Nov 29.

Lewy Body Dementias: Controversies and Drug Development

Chiu SY, Bowers D, Armstrong MJ.

Neurotherapeutics. 2022 Jan;19(1):55-67. doi: 10.1007/s13311-021-01161-z. Epub 2021 Dec 2.

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo-Controlled Trial

Biglan K, Munsie L, Svensson KA, Ardayfio P, Pugh M, Sims J, Brys M.

Mov Disord. 2022 Mar;37(3):513-524. doi: 10.1002/mds.28879. Epub 2021 Dec 2.

Mistaken Identity: Many Diagnoses are Frequently Misattributed to Lyme Disease

Kobayashi T, Higgins Y, Melia MT, Auwaerter PG.

Am J Med. 2022 Apr;135(4):503-511.e5. doi: 10.1016/j.amjmed.2021.10.040. Epub 2021 Nov 30.

Challenges for future theories of Parkinson pathophysiology

Darbin O, Montgomery EB Jr.

Neurosci Res. 2022 Apr;177:1-7. doi: 10.1016/j.neures.2021.11.010. Epub 2021 Nov 30.

Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future

Karaboğa MNS, Sezgintürk MK.

J Pharm Biomed Anal. 2022 Feb 5;209:114479. doi: 10.1016/j.jpba.2021.114479. Epub 2021 Nov 24.

Environmental factors in Parkinson's disease: New insights into the molecular mechanisms

Yuan X, Tian Y, Liu C, Zhang Z.

Toxicol Lett. 2022 Mar 1;356:1-10. doi: 10.1016/j.toxlet.2021.12.003. Epub 2021 Dec 3.

Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer

Hang Z, Lei T, Zeng Z, Cai S, Bi W, Du H.

Biomed Pharmacother. 2022 Jan;145:112343. doi: 10.1016/j.biopha.2021.112343. Epub 2021 Dec 1.

Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study

O'Bryant SE, Petersen M, Zhang F, Johnson L, Mason D, Hall J.

Parkinsonism Relat Disord. 2022 Jan;94:15-21. doi: 10.1016/j.parkreldis.2021.11.027. Epub 2021 Nov 25.

Cognitive and visual processing performance in Parkinson's disease patients with vs without visual hallucinations: A meta-analysis

Montagnese M, Vignando M, Ffytche D, Mehta MA.

Cortex. 2022 Jan;146:161-172. doi: 10.1016/j.cortex.2021.11.001. Epub 2021 Nov 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias